TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Weight Loss Drugs Market Research Report 2023

Global Weight Loss Drugs Market Research Report 2023

  • Category:Life Sciences
  • Published on : 17 December 2022
  • Pages :94
  • Formats:
  • Report Code:SMR-7512999
OfferClick for best price

Best Price: $2320

Weight Loss Drugs Market Size, Share 2022


Market Analysis and Insights: Global Weight Loss Drugs Market

The global Weight Loss Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Weight Loss Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Weight Loss Drugs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Weight Loss Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Weight Loss Drugs market.

Global Weight Loss Drugs Scope and Market Size

Due to the COVID-19 pandemic, the global Weight Loss Drugs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2023-2030. Fully considering the economic change by this health crisis, the Europe Weight Loss Drugs market is estimated at US$ million in 2023, while the United States and China are forecast to reach US$ million and US$ million by 2030, respectively. The proportion of the United States is % in 2023, while Chinese percentage is %, and it is predicted that China market share will reach % in 2030, trailing a CAGR of % through the analysis period. As for the Europe Weight Loss Drugs landscape, Germany is projected to reach US$ million by 2030. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Liauid Weight Loss Drugs accounting for % of the Weight Loss Drugs global market in 2022, is projected to value US$ million by 2030, growing at a revised % CAGR from 2023 to 2030. While Weight-reducing Aid segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2030.

The global major manufacturers of Weight Loss Drugs include Roche, GSK group, Teva, Sandoz(Novartis), STADA-VN J.V.Co., Ltd, Hexal AG, National Company For Pharmaceutical Industry, Lunan Pharmaceutical Group Corporation and Zein Pharmaceutical, etc. In terms of revenue, the global 3 largest players have a % market share of Weight Loss Drugs in 2022.

This report focuses on Weight Loss Drugs volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Weight Loss Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Global Weight Loss Drugs Market: Segment Analysis

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2018 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Liauid Weight Loss Drugs
  • Tablets Weight Loss Drugs

Segment by Application

  • Weight-reducing Aid
  • Other

By Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • U.A.E

By Company

  • Roche
  • GSK group
  • Teva
  • Sandoz(Novartis)
  • STADA-VN J.V.Co., Ltd
  • Hexal AG
  • National Company For Pharmaceutical Industry
  • Lunan Pharmaceutical Group Corporation
  • Zein Pharmaceutical
  • Hisun
  • Taj Pharmaceuticals Ltd
  • Kabir Life Sciences & Research
  • Dm Pharma
  • China Zhongshan Pharm

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Weight Loss Drugs product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Weight Loss Drugs, with price, sales, revenue, and global market share of Weight Loss Drugs from 2019 to 2022.

Chapter 3, the Weight Loss Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Weight Loss Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Weight Loss Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Weight Loss Drugs.

Chapter 13, 14, and 15, to describe Weight Loss Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Weight Loss Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Weight Loss Drugs Market Research Report 2023
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 94 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Weight Loss Drugs Market Overview
1.1 Product Overview and Scope of Weight Loss Drugs
1.2 Weight Loss Drugs Segment by Type
1.2.1 Global Weight Loss Drugs Sales Growth Rate Comparison by Type (2023-2030)
1.2.2 Liauid Weight Loss Drugs
1.2.3 Tablets Weight Loss Drugs
1.3 Weight Loss Drugs Segment by Application
1.3.1 Global Weight Loss Drugs Sales Comparison by Application: (2023-2030)
1.3.2 Weight-reducing Aid
1.3.3 Other
1.4 Global Weight Loss Drugs Market Size Estimates and Forecasts
1.4.1 Global Weight Loss Drugs Revenue 2018-2030
1.4.2 Global Weight Loss Drugs Sales 2018-2030
1.4.3 Weight Loss Drugs Market Size by Region: 2018 Versus 2022 Versus 2030
2 Weight Loss Drugs Market Competition by Manufacturers
2.1 Global Weight Loss Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Weight Loss Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Weight Loss Drugs Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Weight Loss Drugs Manufacturing Sites, Area Served, Product Type
2.5 Weight Loss Drugs Market Competitive Situation and Trends
2.5.1 Weight Loss Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Weight Loss Drugs Players Market Share by Revenue
2.5.3 Global Weight Loss Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Weight Loss Drugs Retrospective Market Scenario by Region
3.1 Global Weight Loss Drugs Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global Weight Loss Drugs Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America Weight Loss Drugs Market Facts & Figures by Country
3.3.1 North America Weight Loss Drugs Sales by Country
3.3.2 North America Weight Loss Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Weight Loss Drugs Market Facts & Figures by Country
3.4.1 Europe Weight Loss Drugs Sales by Country
3.4.2 Europe Weight Loss Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Weight Loss Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Weight Loss Drugs Sales by Region
3.5.2 Asia Pacific Weight Loss Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Weight Loss Drugs Market Facts & Figures by Country
3.6.1 Latin America Weight Loss Drugs Sales by Country
3.6.2 Latin America Weight Loss Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Weight Loss Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Weight Loss Drugs Sales by Country
3.7.2 Middle East and Africa Weight Loss Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Weight Loss Drugs Historic Market Analysis by Type
4.1 Global Weight Loss Drugs Sales Market Share by Type (2018-2023)
4.2 Global Weight Loss Drugs Revenue Market Share by Type (2018-2023)
4.3 Global Weight Loss Drugs Price by Type (2018-2023)
5 Global Weight Loss Drugs Historic Market Analysis by Application
5.1 Global Weight Loss Drugs Sales Market Share by Application (2018-2023)
5.2 Global Weight Loss Drugs Revenue Market Share by Application (2018-2023)
5.3 Global Weight Loss Drugs Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Weight Loss Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Roche Weight Loss Drugs Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 GSK group
6.2.1 GSK group Corporation Information
6.2.2 GSK group Description and Business Overview
6.2.3 GSK group Weight Loss Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GSK group Weight Loss Drugs Product Portfolio
6.2.5 GSK group Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Weight Loss Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Teva Weight Loss Drugs Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Sandoz(Novartis)
6.4.1 Sandoz(Novartis) Corporation Information
6.4.2 Sandoz(Novartis) Description and Business Overview
6.4.3 Sandoz(Novartis) Weight Loss Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sandoz(Novartis) Weight Loss Drugs Product Portfolio
6.4.5 Sandoz(Novartis) Recent Developments/Updates
6.5 STADA-VN J.V.Co., Ltd
6.5.1 STADA-VN J.V.Co., Ltd Corporation Information
6.5.2 STADA-VN J.V.Co., Ltd Description and Business Overview
6.5.3 STADA-VN J.V.Co., Ltd Weight Loss Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 STADA-VN J.V.Co., Ltd Weight Loss Drugs Product Portfolio
6.5.5 STADA-VN J.V.Co., Ltd Recent Developments/Updates
6.6 Hexal AG
6.6.1 Hexal AG Corporation Information
6.6.2 Hexal AG Description and Business Overview
6.6.3 Hexal AG Weight Loss Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Hexal AG Weight Loss Drugs Product Portfolio
6.6.5 Hexal AG Recent Developments/Updates
6.7 National Company For Pharmaceutical Industry
6.6.1 National Company For Pharmaceutical Industry Corporation Information
6.6.2 National Company For Pharmaceutical Industry Description and Business Overview
6.6.3 National Company For Pharmaceutical Industry Weight Loss Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 National Company For Pharmaceutical Industry Weight Loss Drugs Product Portfolio
6.7.5 National Company For Pharmaceutical Industry Recent Developments/Updates
6.8 Lunan Pharmaceutical Group Corporation
6.8.1 Lunan Pharmaceutical Group Corporation Corporation Information
6.8.2 Lunan Pharmaceutical Group Corporation Description and Business Overview
6.8.3 Lunan Pharmaceutical Group Corporation Weight Loss Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Lunan Pharmaceutical Group Corporation Weight Loss Drugs Product Portfolio
6.8.5 Lunan Pharmaceutical Group Corporation Recent Developments/Updates
6.9 Zein Pharmaceutical
6.9.1 Zein Pharmaceutical Corporation Information
6.9.2 Zein Pharmaceutical Description and Business Overview
6.9.3 Zein Pharmaceutical Weight Loss Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Zein Pharmaceutical Weight Loss Drugs Product Portfolio
6.9.5 Zein Pharmaceutical Recent Developments/Updates
6.10 Hisun
6.10.1 Hisun Corporation Information
6.10.2 Hisun Description and Business Overview
6.10.3 Hisun Weight Loss Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Hisun Weight Loss Drugs Product Portfolio
6.10.5 Hisun Recent Developments/Updates
6.11 Taj Pharmaceuticals Ltd
6.11.1 Taj Pharmaceuticals Ltd Corporation Information
6.11.2 Taj Pharmaceuticals Ltd Weight Loss Drugs Description and Business Overview
6.11.3 Taj Pharmaceuticals Ltd Weight Loss Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Taj Pharmaceuticals Ltd Weight Loss Drugs Product Portfolio
6.11.5 Taj Pharmaceuticals Ltd Recent Developments/Updates
6.12 Kabir Life Sciences & Research
6.12.1 Kabir Life Sciences & Research Corporation Information
6.12.2 Kabir Life Sciences & Research Weight Loss Drugs Description and Business Overview
6.12.3 Kabir Life Sciences & Research Weight Loss Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Kabir Life Sciences & Research Weight Loss Drugs Product Portfolio
6.12.5 Kabir Life Sciences & Research Recent Developments/Updates
6.13 Dm Pharma
6.13.1 Dm Pharma Corporation Information
6.13.2 Dm Pharma Weight Loss Drugs Description and Business Overview
6.13.3 Dm Pharma Weight Loss Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Dm Pharma Weight Loss Drugs Product Portfolio
6.13.5 Dm Pharma Recent Developments/Updates
6.14 China Zhongshan Pharm
6.14.1 China Zhongshan Pharm Corporation Information
6.14.2 China Zhongshan Pharm Weight Loss Drugs Description and Business Overview
6.14.3 China Zhongshan Pharm Weight Loss Drugs Sales, Revenue and Gross Margin (2018-2023)
6.14.4 China Zhongshan Pharm Weight Loss Drugs Product Portfolio
6.14.5 China Zhongshan Pharm Recent Developments/Updates
7 Weight Loss Drugs Manufacturing Cost Analysis
7.1 Weight Loss Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Weight Loss Drugs
7.4 Weight Loss Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Weight Loss Drugs Distributors List
8.3 Weight Loss Drugs Customers
9 Weight Loss Drugs Market Dynamics
9.1 Weight Loss Drugs Industry Trends
9.2 Weight Loss Drugs Market Drivers
9.3 Weight Loss Drugs Market Challenges
9.4 Weight Loss Drugs Market Restraints
10 Global Market Forecast
10.1 Weight Loss Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Weight Loss Drugs by Type (2023-2030)
10.1.2 Global Forecasted Revenue of Weight Loss Drugs by Type (2023-2030)
10.2 Weight Loss Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Weight Loss Drugs by Application (2023-2030)
10.2.2 Global Forecasted Revenue of Weight Loss Drugs by Application (2023-2030)
10.3 Weight Loss Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Weight Loss Drugs by Region (2023-2030)
10.3.2 Global Forecasted Revenue of Weight Loss Drugs by Region (2023-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Weight Loss Drugs Sales Growth Rate Comparison by Type (2023-2030) & (K Tablets) & (US$ Million)
Table 2. Global Weight Loss Drugs Sales Growth Rate Comparison by Application (2023-2030) & (K Tablets) & (US$ Million)
Table 3. Global Weight Loss Drugs Market Size by Region (US$ Million) (2018 VS 2022 VS 2030)
Table 4. Global Weight Loss Drugs Market Competitive Situation by Manufacturers in 2022
Table 5. Global Weight Loss Drugs Sales (K Tablets) of Key Manufacturers (2018-2023)
Table 6. Global Weight Loss Drugs Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Weight Loss Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 8. Global Weight Loss Drugs Revenue Share by Manufacturers (2018-2023)
Table 9. Global Market Weight Loss Drugs Average Price (USD/Tablet) of Key Manufacturers (2018-2023)
Table 10. Manufacturers Weight Loss Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Weight Loss Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Weight Loss Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Weight Loss Drugs as of 2022)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Weight Loss Drugs Sales by Region (2018-2023) & (K Tablets)
Table 16. Global Weight Loss Drugs Sales Market Share by Region (2018-2023)
Table 17. Global Weight Loss Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 18. Global Weight Loss Drugs Revenue Market Share by Region (2018-2023)
Table 19. North America Weight Loss Drugs Sales by Country (2018-2023) & (K Tablets)
Table 20. North America Weight Loss Drugs Sales Market Share by Country (2018-2023)
Table 21. North America Weight Loss Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 22. North America Weight Loss Drugs Revenue Market Share by Country (2018-2023)
Table 23. Europe Weight Loss Drugs Sales by Country (2018-2023) & (K Tablets)
Table 24. Europe Weight Loss Drugs Sales Market Share by Country (2018-2023)
Table 25. Europe Weight Loss Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 26. Europe Weight Loss Drugs Revenue Market Share by Country (2018-2023)
Table 27. Asia Pacific Weight Loss Drugs Sales by Region (2018-2023) & (K Tablets)
Table 28. Asia Pacific Weight Loss Drugs Sales Market Share by Region (2018-2023)
Table 29. Asia Pacific Weight Loss Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 30. Asia Pacific Weight Loss Drugs Revenue Market Share by Region (2018-2023)
Table 31. Latin America Weight Loss Drugs Sales by Country (2018-2023) & (K Tablets)
Table 32. Latin America Weight Loss Drugs Sales Market Share by Country (2018-2023)
Table 33. Latin America Weight Loss Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Latin America Weight Loss Drugs Revenue Market Share by Country (2018-2023)
Table 35. Middle East and Africa Weight Loss Drugs Sales by Country (2018-2023) & (K Tablets)
Table 36. Middle East and Africa Weight Loss Drugs Sales Market Share by Country (2018-2023)
Table 37. Middle East and Africa Weight Loss Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 38. Middle East and Africa Weight Loss Drugs Revenue Market Share by Country (2018-2023)
Table 39. Global Weight Loss Drugs Sales by Type (2018-2023) & (K Tablets)
Table 40. Global Weight Loss Drugs Sales Market Share by Type (2018-2023)
Table 41. Global Weight Loss Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 42. Global Weight Loss Drugs Revenue Share by Type (2018-2023)
Table 43. Global Weight Loss Drugs Price by Type (2018-2023) & (USD/Tablet)
Table 44. Global Weight Loss Drugs Sales (K Tablets) by Application (2018-2023)
Table 45. Global Weight Loss Drugs Sales Market Share by Application (2018-2023)
Table 46. Global Weight Loss Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global Weight Loss Drugs Revenue Share by Application (2018-2023)
Table 48. Global Weight Loss Drugs Price by Application (2018-2023) & (USD/Tablet)
Table 49. Roche Corporation Information
Table 50. Roche Description and Business Overview
Table 51. Roche Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2018-2023)
Table 52. Roche Weight Loss Drugs Product
Table 53. Roche Recent Developments/Updates
Table 54. GSK group Corporation Information
Table 55. GSK group Description and Business Overview
Table 56. GSK group Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2018-2023)
Table 57. GSK group Weight Loss Drugs Product
Table 58. GSK group Recent Developments/Updates
Table 59. Teva Corporation Information
Table 60. Teva Description and Business Overview
Table 61. Teva Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2018-2023)
Table 62. Teva Weight Loss Drugs Product
Table 63. Teva Recent Developments/Updates
Table 64. Sandoz(Novartis) Corporation Information
Table 65. Sandoz(Novartis) Description and Business Overview
Table 66. Sandoz(Novartis) Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2018-2023)
Table 67. Sandoz(Novartis) Weight Loss Drugs Product
Table 68. Sandoz(Novartis) Recent Developments/Updates
Table 69. STADA-VN J.V.Co., Ltd Corporation Information
Table 70. STADA-VN J.V.Co., Ltd Description and Business Overview
Table 71. STADA-VN J.V.Co., Ltd Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2018-2023)
Table 72. STADA-VN J.V.Co., Ltd Weight Loss Drugs Product
Table 73. STADA-VN J.V.Co., Ltd Recent Developments/Updates
Table 74. Hexal AG Corporation Information
Table 75. Hexal AG Description and Business Overview
Table 76. Hexal AG Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2018-2023)
Table 77. Hexal AG Weight Loss Drugs Product
Table 78. Hexal AG Recent Developments/Updates
Table 79. National Company For Pharmaceutical Industry Corporation Information
Table 80. National Company For Pharmaceutical Industry Description and Business Overview
Table 81. National Company For Pharmaceutical Industry Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2018-2023)
Table 82. National Company For Pharmaceutical Industry Weight Loss Drugs Product
Table 83. National Company For Pharmaceutical Industry Recent Developments/Updates
Table 84. Lunan Pharmaceutical Group Corporation Corporation Information
Table 85. Lunan Pharmaceutical Group Corporation Description and Business Overview
Table 86. Lunan Pharmaceutical Group Corporation Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2018-2023)
Table 87. Lunan Pharmaceutical Group Corporation Weight Loss Drugs Product
Table 88. Lunan Pharmaceutical Group Corporation Recent Developments/Updates
Table 89. Zein Pharmaceutical Corporation Information
Table 90. Zein Pharmaceutical Description and Business Overview
Table 91. Zein Pharmaceutical Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2018-2023)
Table 92. Zein Pharmaceutical Weight Loss Drugs Product
Table 93. Zein Pharmaceutical Recent Developments/Updates
Table 94. Hisun Corporation Information
Table 95. Hisun Description and Business Overview
Table 96. Hisun Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2018-2023)
Table 97. Hisun Weight Loss Drugs Product
Table 98. Hisun Recent Developments/Updates
Table 99. Taj Pharmaceuticals Ltd Corporation Information
Table 100. Taj Pharmaceuticals Ltd Description and Business Overview
Table 101. Taj Pharmaceuticals Ltd Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2018-2023)
Table 102. Taj Pharmaceuticals Ltd Weight Loss Drugs Product
Table 103. Taj Pharmaceuticals Ltd Recent Developments/Updates
Table 104. Kabir Life Sciences & Research Corporation Information
Table 105. Kabir Life Sciences & Research Description and Business Overview
Table 106. Kabir Life Sciences & Research Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2018-2023)
Table 107. Kabir Life Sciences & Research Weight Loss Drugs Product
Table 108. Kabir Life Sciences & Research Recent Developments/Updates
Table 109. Dm Pharma Corporation Information
Table 110. Dm Pharma Description and Business Overview
Table 111. Dm Pharma Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2018-2023)
Table 112. Dm Pharma Weight Loss Drugs Product
Table 113. Dm Pharma Recent Developments/Updates
Table 114. China Zhongshan Pharm Corporation Information
Table 115. China Zhongshan Pharm Description and Business Overview
Table 116. China Zhongshan Pharm Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2018-2023)
Table 117. China Zhongshan Pharm Weight Loss Drugs Product
Table 118. China Zhongshan Pharm Recent Developments/Updates
Table 119. Production Base and Market Concentration Rate of Raw Material
Table 120. Key Suppliers of Raw Materials
Table 121. Weight Loss Drugs Distributors List
Table 122. Weight Loss Drugs Customers List
Table 123. Weight Loss Drugs Market Trends
Table 124. Weight Loss Drugs Market Drivers
Table 125. Weight Loss Drugs Market Challenges
Table 126. Weight Loss Drugs Market Restraints
Table 127. Global Weight Loss Drugs Sales Forecast by Type (2023-2030) & (K Tablets)
Table 128. Global Weight Loss Drugs Sales Market Share Forecast by Type (2023-2030)
Table 129. Global Weight Loss Drugs Revenue Forecast by Type (2023-2030) & (US$ Million)
Table 130. Global Weight Loss Drugs Revenue Market Share Forecast by Type (2023-2030)
Table 131. Global Weight Loss Drugs Sales Forecast by Application (2023-2030) & (K Tablets)
Table 132. Global Weight Loss Drugs Sales Market Share Forecast by Application (2023-2030)
Table 133. Global Weight Loss Drugs Revenue Forecast by Application (2023-2030) & (US$ Million)
Table 134. Global Weight Loss Drugs Revenue Market Share Forecast by Application (2023-2030)
Table 135. Global Weight Loss Drugs Sales Forecast by Region (2023-2030) & (K Tablets)
Table 136. Global Weight Loss Drugs Sales Market Share Forecast by Region (2023-2030)
Table 137. Global Weight Loss Drugs Revenue Forecast by Region (2023-2030) & (US$ Million)
Table 138. Global Weight Loss Drugs Revenue Market Share Forecast by Region (2023-2030)
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Weight Loss Drugs
Figure 2. Global Weight Loss Drugs Market Share by Type in 2022 & 2030
Figure 3. Liauid Weight Loss Drugs Product Picture
Figure 4. Tablets Weight Loss Drugs Product Picture
Figure 5. Global Weight Loss Drugs Market Share by Application in 2022 & 2030
Figure 6. Weight-reducing Aid
Figure 7. Other
Figure 8. Global Weight Loss Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2030
Figure 9. Global Weight Loss Drugs Market Size (2018-2030) & (US$ Million)
Figure 10. Global Weight Loss Drugs Sales (2018-2030) & (K Tablets)
Figure 11. Weight Loss Drugs Sales Share by Manufacturers in 2022
Figure 12. Global Weight Loss Drugs Revenue Share by Manufacturers in 2022
Figure 13. The Global 5 and 10 Largest Weight Loss Drugs Players: Market Share by Revenue in 2022
Figure 14. Weight Loss Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 15. Global Weight Loss Drugs Sales Market Share by Region (2018-2023)
Figure 16. Global Weight Loss Drugs Sales Market Share by Region in 2022
Figure 17. Global Weight Loss Drugs Revenue Market Share by Region (2018-2023)
Figure 18. Global Weight Loss Drugs Revenue Market Share by Region in 2022
Figure 19. U.S. Weight Loss Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 20. Canada Weight Loss Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 21. Germany Weight Loss Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 22. France Weight Loss Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 23. U.K. Weight Loss Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 24. Italy Weight Loss Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 25. Russia Weight Loss Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 26. China Weight Loss Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 27. Japan Weight Loss Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 28. South Korea Weight Loss Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 29. India Weight Loss Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 30. Australia Weight Loss Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 31. Taiwan Weight Loss Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 32. Indonesia Weight Loss Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 33. Thailand Weight Loss Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 34. Malaysia Weight Loss Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 35. Philippines Weight Loss Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 36. Vietnam Weight Loss Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 37. Mexico Weight Loss Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 38. Brazil Weight Loss Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 39. Argentina Weight Loss Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 40. Turkey Weight Loss Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 41. Saudi Arabia Weight Loss Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 42. U.A.E Weight Loss Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 43. Sales Market Share of Weight Loss Drugs by Type (2018-2023)
Figure 44. Manufacturing Cost Structure of Weight Loss Drugs
Figure 45. Manufacturing Process Analysis of Weight Loss Drugs
Figure 46. Weight Loss Drugs Industrial Chain Analysis
Figure 47. Channels of Distribution
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount